Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announces its commercial partnership for ColoAlert with Fugene Genetics, a renowned genetic testing service provider based in Israel.
Fugene Genetics, established in 2008, offers a wide range of advanced genetic testing services to private clients, health organizations, hospitals, and genetic institutes throughout the country.
ColoAlert is Mainz Biomed
